Trade Report: Today, Israel Chemicals Ltd. (ICL) Announces Quarterly Earnings Results, Hits Expectations

Today, Israel Chemicals Ltd. (ICL) Announces Quarterly  Earnings Results, Hits Expectations

Israel Chemicals Ltd. (NYSE:ICL) posted its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. Israel Chemicals had a net margin of 7.40% and a return on equity of 17.44%. The business earned $1.38 billion during the quarter. During the same period in the previous year, the business posted $0.12 EPS. The business’s revenue for the quarter was up .3% compared to the same quarter last year.

Israel Chemicals (NYSE:ICL) opened at 3.80 on Friday. The company has a market capitalization of $4.84 billion, a PE ratio of 11.99 and a beta of 1.14. The firm’s 50-day moving average price is $3.74 and its 200 day moving average price is $3.99. Israel Chemicals has a 52 week low of $3.52 and a 52 week high of $5.23.

A number of hedge funds have recently made changes to their positions in the stock. Jarislowsky Fraser Ltd increased its stake in shares of Israel Chemicals by 3.1% in the second quarter. Jarislowsky Fraser Ltd now owns 29,084 shares of the company’s stock valued at $113,000 after buying an additional 887 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Israel Chemicals by 1.6% in the second quarter. Alliancebernstein L.P. now owns 496,495 shares of the company’s stock valued at $1,936,000 after buying an additional 7,874 shares during the last quarter. Nikko Asset Management Americas Inc. increased its stake in shares of Israel Chemicals by 1.2% in the second quarter. Nikko Asset Management Americas Inc. now owns 714,283 shares of the company’s stock valued at $2,807,000 after buying an additional 8,800 shares during the last quarter. Public Sector Pension Investment Board increased its stake in shares of Israel Chemicals by 19.0% in the second quarter. Public Sector Pension Investment Board now owns 96,656 shares of the company’s stock valued at $374,000 after buying an additional 15,400 shares during the last quarter. Finally, Foyston Gordon & Payne Inc increased its stake in shares of Israel Chemicals by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock valued at $7,834,000 after buying an additional 16,631 shares during the last quarter. Hedge funds and other institutional investors own 6.51% of the company’s stock.

Separately, Zacks Investment Research raised shares of Israel Chemicals from a “hold” rating to a “buy” rating and set a $4.25 price target for the company in a research report on Monday.

Related posts

Leave a Comment